DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Emgel is a drug marketed by Altana and is included in one NDA.
The generic ingredient in EMGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Twenty-nine suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
A generic version of EMGEL was approved as erythromycin by TORRENT on July 6th, 2020.
Anatomical Therapeutic Chemical (ATC) Classes for EMGEL
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Altana||EMGEL||erythromycin||GEL;TOPICAL||063107-001||Aug 23, 1991||DISCN||No||No||⤷ Try it Free||⤷ Try it Free||⤷ Try it Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|